Pocket Oncology (Pocket Notebook Series), 1st Ed.

ABBREVIATIONS

&

And

ΔMS

Change in mental status

Primary

Secondary

3DCRT

3D conformal Radiotherapy

5-FU

5-fluorouracil

6-MP

6-mercaptopurine

Alkaline phosphatase

a/w

Associated with

AA

African-american

AASLD

American Association for Study of Liver Diseases

Ab

Antibody

ABC

Activated B-cell

abd wall

Abdominal wall

abnl

Abnormal

ABVD

Doxorubicin, bleomycin, vinblastine, dacarbazine

ABW

Actual body weight

abx

Antibiotics

AC

Assist control

ACC

Adrenal cortex carcinomas

ACL

Anticardiolipin antibody

ACS

Acute coronary syndrome

ACT

Adoptive cell therapy

ACTH

Adrenocorticotropic hormone

ACV

Acyclovir

ADA

Adenosine deaminase

ADCC

Antibody-dependent cellular cytotoxicity

ADCL

Adenocarcinoma of the lung

ADH

Antidiuretic hormone

ADSQLC

Adenosquamous cell lung cancer

ADT

Androgen deprivation therapy

adv

Advanced

AEs

Adverse events

AF

Atrial fibrillation

AFB

Acid-fast bacilli

AFP

α-fetoprotein

AG

Aminoglycoside

Ag

Antigen

AICARFT

5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase

AIDS

Acquired immunodeficiency syndrome

AIHA

Autoimmune hemolytic anemia

AIM

Doxorubicin, ifofsamide, mesna

AIIR

Airborne infection isolation room

AIN

Acute interstitial nephritis

AIN

Anal intraepithelial neoplasia

AIP

Acute intermittent porphyria

AITL

Angioimmunoblastic T cell lymphoma

AJ

Ashkenazi Jewish

AJCC

American Joint Committee on Cancer

AKI

Acute kidney injury

ALA

Aminolevulinic acid

ALC

Absolute lymphocyte count

ALCL

Anaplastic large-cell lymphoma

ALK

Anaplastic lymphoma kinase

ALL

Acute lymphoblastic leukemia

ALT

Alanine aminotransferase

AML

Acute myelogenous leukemia

amp

Amplification

ANC

Absolute neutrophil count

angio

Angiogram

AOCI

Anemia of chronic inflammation

APC

Activated protein C

APL

Acute promyeloctic leukemia

APLA

Antiphospholipid antibody

APR

Abdominal perineal resection

APS

Antiphospholipid antibody syndrome

ara-CTP

Arabinofuranosylcytosine triphosphate

ARDS

Acute respiratory distress syndrome

ASA

Aspirin

ASCR

Autologous stem cell rescue

ASCT

Autologous stem cell transplantation

ASM

Aggressive systemic mastocytosis

AST

Aspartate aminotransferase

asx

Asymptomatic

AT

Accelerated titration

ATG

Antithymocyte globulin

ATIII

Antithrombin III

ATLL

Adult T cell lymphoma and leukemia

ATO

Arsenic trioxide

ATRA

All-trans-retinoic acid

AV

Atrioventricular

Avg

Average

AVN

Avascular necrosis

AZA

Azathioprine

B2M

β2-microglobulin

b/c

Because

BAC

Bronchioloalveolar carcinoma

BBB

Bundle branch block

BBW

black box warning

BC

Breast cancer

BCC

Basal cell carcinoma

BCLC

Barcelona-Clιnic Liver Cancer

BCR

B cell receptors

BCS

Breast-conserving surgery

BCx

Blood culture

BD

Bile duct

BEACOPP

Bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, & prednisone

BER

Base-excision repair

Bev

Bevacizumab

bili.

Bilirubin

BiV

Biventricular

BM

Bone marrow

 

Bowel movement

BMA

Bone-modifying agents

BMD

Bone mineral density

BMI

Body mass index

BMP

Basic metabolic profile

BMT

Bone marrow transplant

BOOP

Bronchiolitis obliterans with organizing pneumonia

bp

Base pairs

BP

Blood pressure

BPT

Bleomycin pulmonary toxicity

BS

Breath sounds

BSC

Best supportive care

BTA

Bladder tumor antigen

BUN

Blood urea nitrogen

BW

Body weight

bx

Biopsy

c/w

Compared with

 

Consistent with

C′

Complement

CA

Cancer

CAD

Coronary artery disease

CAF

Cyclophosphamide/doxorubicin/fluorouracil

Cap

Capecitabine

CAPD

Chronic ambulatory peritoneal dialysis

CAR

Chimeric antigen receptor

CAV

Cyclophosphamide, adriamycin (doxorubicin), vincristine

CBC

Complete blood count

CBD

Common bile duct

CBE

Clinical breast exam

CBF

Core-binding factor

CC

Cholangiocarcinomas

CCND1

Cyclin D1

ccRCC

Clear cell renal cell cancer/clear cell renal cell carcinoma

CCY

Cholecystectomy

CD

Crohn disease

CDI

Clostridium difficile Infection

CDKs

Cyclin-dependent kinases

CEA

Carcinoembryonic antigen

 

Carotid endarterectomy

CEP

Congenital erythropoietic porphyria

ceph.

Cephalosporin

Cftx

Ceftriaxone

CFU

Colony forming units

CgA

Chromogranin A

CHF

Congestive heart failure

ChIP

Chromatin ImmunoPrecipitation

CHOEP

CHOP plus etoposide

CHOP

Cyclophosphamide, doxorubicin, vincristine & prednisone

CHR

Complete hematologic response

CI

Cardiac index

CIMP

CpG island methylator phenotype

CIN

Cervical intraepithelial neoplasia

CIS

Cisplatin

CK

Cytokeratin

CKD

Chronic kidney disease

CLIA

Clinical Laboratory Improvement Amendments

CLL

Chronic lymphocytic leukemia

CLPs

Common lymphoid progenitors

CML

Chronic myelogenous leukemia

CMML

Chronic myelomonocytic leukemia

CMP

Cardiomyopathy

 

Common myeloid progenitor

CMT

Combined modality treatment

CMV

Cytomegalovirus

CN

Cranial nerve

CNS

Central nervous system

COG

Children’s Oncology Group

conc.

Concentration

COPD

Chronic obstructive pulmonary disease

CP

Chest pain

CR

Complete response

Cr

Creatinine

CRBSI

Catheter-related Bloodstream Infection

CRC

Colorectal cancer

CrCl

Creatinine clearance

CRI

Chronic renal insufficiency

CRM

Circumferential resection margin

CRM

Continual reassessment method

CRP

C-reactive protein

CRPC

Castration-resistant prostate cancer

CsA

Cyclosporine A

CSF

Cerebrospinal fluid

CT

Computed tomogram

CTCL

Cutaneous T-cell lymphoma

CTD

Connective tissue disease

CTEP

Cancer Therapy Evaluation Program

CTL

Cytotoxic T cell

CUP

Cancer of Unknown Primary

CV

Cardiovascular

CVA

Cerebrovascular accident

CVAD

Cyclophosphamide, vincristine, doxorubicin, and dexamethasone

CVP

Central venous pressure

CVT

Cisplatin, vinblastine, temozolomide

CW

Chest wall

cx

Culture

CXR

Chest radiograph

d

Day

d/c

Discontinue

DA

Dopamine

DAT

Direct antiglobulin test

DBP

Diastolic blood pressure

DC

Dendritic Cell

 

Docetaxel and cyclophosphamide

DDI

Drug-drug interactions

ddNTP

Dideoxynucleotide triphosphates

Ddx

Differential diagnosis

DES

Drug-eluting stent

 

Des-gamma-carboxyprothrombin

DFS

Disease-free survival

DHAP

Dexamethasone, cytarabine, CIS

DHEA

Dehydroepiandrosterone

DHFR

Dihydrofolate reductase

DHTR

Delayed Hemolytic Transfusion Reaction

DI

Diabetes insipidus

DIC

Disseminated intravascular coagulation

diff.

Differential

DIPSS

Dynamic IPSS

DKA

Diabetic ketoacidosis

DLBCL

Diffuse large B-cell lymphoma

DLCO

Diffusion capacity of the lung

DLI

Donor lymphocyte infusion

DLT

Dose-limiting toxicity

DM

Dermatomyositis

 

Diabetes mellitus

DNMT

DNA methyltransferase

dNTPs

Deoxynucleotide triphosphates

DOE

Dyspnea on exertion

DPD

Dihydropyrimidine dehydrogenase

DRE

Digital rectal exam

DS

Durie-Salmon

DTIC

Dacarbazine

DSBs

Double strand breaks

DSMB

Data safety monitoring board

DSNB

Dynamic sentinel node biopsy

DVT

Deep vein thrombosis

dx

Diagnosis

dz

Disease

EBRT

External beam radiation therapy

EBUS

Endobronchial US

EBV

Epstein-Barr virus

ECF

Epirubicin, CIS, 5-FU

ECG

Electrocardiogram

echo

Echocardiogram

ECX

Epirubicin, CIS, Cap

EF

Ejection fraction

EFS

Event-free survival

EGD

Esophagogastroduodenoscopy

EGFR

Epidermal growth factor receptor

EGJ

Esophagogastric junction

ELISA

Enzyme-linked immunosorbent assay

EM

Electron microscopy

EMT

Epithelial-to-mesenchymal transition

ENETS

European Neuroendocrine Tumor Society

ENMZL

Extranodal marginal zone lymphoma

EOD

Extent of disease

EOX

Epirubicin, OX, Cap

EPIC

Early postoperative intraperitoneal chemotherapy

Epo

Erythropoietin

EPP

Extrapleural pneumonectomy

 

Erythropoietic protoporphyria

ER

Estrogen receptor

ERCP

Endoscopic retrograde cholangiopancreatography

ERSPC

European Randomized Study of Screening for Prostate Cancer

ESAs

Erythropoiesis-stimulating agents

ESBL

Extended spectrum beta-lactamase

ESCC

Epidural spinal cord compression scale

ESFT

Ewing sarcoma family of tumors

ESP

End-systolic pressure

ESR

Erythrocyte sedimentation rate

ESRD

End-stage renal disease

ET

Essential thrombocythemia

ETT

Endotracheal tube

EtOH

Alcohol

EUS

Endoscopic ultrasound

FAD

Food and drug administration

FAMMM

Familial atypical multiple mole melanoma syndrome

FAP

Familial adenomatous polyposis

FDG

Fluorodeoxyglucose

FDR

False Discovery Rate

FDUMP

5-fluorodeoxyuridine monophosphate

FEV1

Forced expiratory volume in 1 second

FFP

Fresh frozen plasma

FFTF

Freedom from treatment failure

FGFR

Fibroblast growth factor receptor

FHx

Family history

FISH

Fluorescent in situ hybridizations

FL

Follicular lymphoma

FLC

Free light chain

FMTC

Familial medullary thyroid CA

FMTC

Familial medullary thyroid carcinoma

FN

False negative/false –

FNA

Fine needle aspiration

FOBT

Fecal occult blood testing

FP

False positive/false +

FQ

Fluoroquinolone

FSC

Forward scatter

FSH

Follicle stimulating hormone

FUO

Fever of unknown origin

FVC

Forced vital capacity

G6PD

Glucose-6-phosphate dehydrogenase

GARFT

glycinamide ribonucleotide formyltransferase

GB

Gallbladder

GBC

Gallbladder cancer

GBM

Glomerular basement membrane

GC

Gemcitabine, cisplatin

GCB

Germinal Center B-cell

GCP

Good clinical practice

G-CSF

Granulocyte colony stimulating factor

GCT

Germ cell tumor

GE

Gastroesophageal

GEJ

Gastroesophageal junction

GELF

Groupe d’Etude des Lymphomes Folliculaires

GEM

Gemcitabine

gen.

Generation

GERD

Gastroesophageal reflux disease

GFR

Glomerular filtration rate

GGT

γ-glutamyl transpeptidase

GH

Growth hormone

GI

Gastrointestinal

GIB

Gastrointestinal bleed

GIST

Gastrointestinal stromal tumor

glc

Glucose

GM1

Ganglioside M1

GM-CSF

Granulocyte-macrophage colony-stimulating factor

GNR

Gram negative rods

GnRH

Gonadotropin releasing hormone

GOC

Goals of care

GPA

Graded Prognostic Assessment

GPC

Gram positive cocci

GTN

Gestational trophoblastic neoplasia

GU

Gastric ulcer

GVHD

Graft-versus-host disease

h

Hour

h/o

History of

H2RA

H2-receptor antagonist

HA

Headache

HAART

Highly active antiretroviral therapy

HAV

Hepatitis A virus

Hb

Hemoglobin

HBV

Hepatitis B virus

HCC

Hepatocellular carcinoma

hCG

Human chorionic gonadotropin

HCL

Hairy cell leukemia

HCP

Hereditary coproporphyria

Hct

Hematocrit

HCT-CI

Hematopoietic Cell Transplantation-Specific Comorbidity Index

HCV

Hepatitis C virus

HD

Hemodialysis

HDAC

Histone deacetylase

HDC

High-dose chemotherapy

HD-MTX

High-dose methotrexate

HDT

High-dose therapy

HE

Hereditary Elliptocytosis

HE-4

Human epididymis protein 4

HELLP

Hemolysis, abnormal LFTs, low platelets

HELP

HpaII tiny fragment Enrichment by Ligation-mediated PCR

HEP

Hepatoerythropoietic Porphyria

HF

Heart failure

HFS

Hand-foot syndrome

HGS

High-grade serous

HIF

Hypoxia-inducible factor

HIPAA

Health Insurance Portability and Accountability Act

HIPEC

Hyperthermic intraperitoneal chemotherapy

HIT

Heparin-induced thrombocytopenia

HITT

Heparin-induced Thrombocytopenia and Thrombosis

HIV

Human immunodeficiency virus

HL

Hodgkin lymphoma

HLA

Human leukocyte antigen

HMP

Hexose Monophosphate

HNPCC

Hereditary nonpolyposis colorectal cancer

HNSCC

Head and neck squamous cell carcinoma

HoTN

Hypotension

hpf

High power field

HPP

Hereditary pyropoikilocytosis

HPT

Hyperparathyroidism

HPV

Human papillomavirus

HR

Hazard Ratio

HR

Heart rate

HR

Homologous recombination

HRT

Hormone replacement therapy

HS

Hereditary spherocytosis

HSC

Hematopoietic stem cell

HSCT

Hematopoietic stem cell transplantation

HSIL

High-grade squamous intraepithelial

HSM

Hepatosplenomegaly

HSR

Hypersensitivity reaction

HSV

Herpes simplex virus

HTLV-1

Human T-lymphotropic virus

HTN

Hypertension

HUS

Hemolytic uremic syndrome

hx

History

IABP

Intra-aortic balloon pump

IAP

Inhibitor of apoptosis

IBD

Inflammatory bowel disease

IBW

Ideal body weight

ICE

Ifosfamide, carboplatin, etoposide

ICH

International conference on harmonization

ICH

Intracranial hemorrhage

ICOS

Inducible costimulator

ICP

Intracranial pressure

ICU

Intensive care unit

IDC

Invasive ductal carcinoma

IDO

Indoleamine 2,3-dioxygenase

IDT

Interdisciplinary team

IE

Ifosfamide + etoposide

IE

Infective endocarditis

IF

Intrinsic factor

IFE

Immunofixation electrophoresis

IFN

Interferon

IFRT

Involved-field radiotherapy

Ig

Immunoglobulin

IGCCCG

International Germ Cell Cancer Collaborative Group

IGF

Insulin-like growth factor

IGRT

Image-guided radiation therapy

IHC

Immunohistochemistry

IHH

Indian Hedgehog

IITs

Investigator-initiated trials

ILC

Invasive lobular carcinoma

IMIG

International Mesothelioma Interest Group

IMRT

Image-guided intensity-modulated RT

IND

Investigational new drug

info

Information

infxn

Infection

inh

Inhaled

INH

Isoniazid

inj

Injection

INR

International normalized ratio

IORT

Intraoperative radiation therapy

IPHC

Intraperitoneal heated chemotherapy

IPI

International Prognostic Index

IPS

International Prognostic Score

IPSS

International Prognostic Scoring System

IR

Ionizing Radiation

irAEs

Immune-related adverse events

IRB

Institutional review board

irRC

Immune-related response criteria

IS

International Scale

ISM

Indolent systemic mastocytosis

ISRT

Involved Site Radiation Therapy

ISS

International Staging System

ISTs

Industry-sponsored trials

IT

Intrathecal

ITP

Idiopathic thrombocytopenic purpura

IV

Intravenous

IVB

Intravenous bolus

IVC

Inferior vena cava

IVF

Intravenous fluids

IVIg

Intravenous immunoglobulin

IVP

Intravenous push

jxn

Junction

KIRs

Killer immunoglobulin-like receptors

KPC

Klebsiella pneumoniae carbapenemase

LA

Long-acting

 

Lupus anticoagulant

LAD

Left anterior descending coronary artery

 

Left axis deviation

LAN

Lymphadenopathy

LBL

Acute lymphoblastic lymphoma

LCA

Left coronary artery

LCA

Leukocyte common Antigen

LDCT

Low-dose computed tomography

LDH

Lactate dehydrogenase

LDR

Low–dose–rate

LE

Lower extremity

LEEP

Loop electrical excision procedure

LFS

Li–fraumeni syndrome

LFTs

Liver function tests

LGRs

Large genomic rearrangements

LH

Luteinizing hormone

LHRH

Luteinizing-hormone-releasing hormone

LINACs

Linear accelerators

LMWH

Low-molecular-weight heparin

LN

Lymph node

LND

Lymph node dissection

LOH

Loss of heterozygosity

LP

Lumbar puncture

LPL

Lymphoplasmacytic lymphoma

LS

Lynch Syndrome

LV

Left ventricle

LVEF

Left ventricular ejection fraction

LVI

Lymphovascular invasion

LVSI

Lymphovascular space invasion

Macrophage

MAG

Myelin-associated glycoprotein

MAHA

Microangiopathic hemolytic anemia

MALT

Mucosa-associated lymphoid tissue

MAO

Monoamine oxidase

MAP

Mean arterial pressure

MAP

MYH-Associated Polyposis

MAPK

Mitogen-activated protein kinase

MBC

Metastatic breast cancer

MCL

Mast cell leukemia

 

Mantle cell lymphoma

MCV

Mean corpuscular volume

MDR-1

Multi-drug resistance 1

MDRO

Multi-drug resistant organism

MDS

Myelodysplastic syndrome

MDSC

Myeloid-derived suppressor cells

MED

Minimum efficacious dose

MEN

Multiple endocrine neoplasia

met

Metastasis/metastatic

mets

Metastases

MF

Mycosis fungoides

MF

Myelofibrosis

MFH

Malignant fibrous histiocytoma

MG

Myasthenia gravis

mgmt

Management

MGMT

Methyl guanine methyltransferase

MGUS

Monoclonal gammopathy of undetermined significance

MHC

Major histocompatibility complex

MI

Myocardial infarction

min

Minute

min.

Minimal

MIPI

Mantle Cell IPI

MIS

Microsatellite instability

MM

Multiple myeloma

MMA

Methylmalonic acid

MMC

Mitomycin C

MMF

Mycophenolate mofetil

MMR

Mismatch repair

MN

Membranous nephropathy

MNZ

Metronidazole

MOA

Mechanism of action

mod.

Moderate

mos

Months

MPGN

Membranoproliferative glomerulonephritis

MPN

Myeloproliferative neoplasm

MR

Magnetic resonance

 

Mitral regurgitation

MRCP

Magnetic resonance cholangiopancreatography

MRI

Magnetic resonance imaging

MRSA

Methicillin-resistant S. aureus

MS

Mitral stenosis

MSI

Microsatellite instability

MSKCC

Memorial Sloan–Kettering Cancer Center

MSSA

Methicillin-Sensitive Staphylococcus aureus

MSTS

Metastatic soft tissue sarcoma

Mt

Mutation

MTb

Mycobacterium tuberculosis

MTC

Medullary thyroid CA

MTD

Maximum-tolerated dose

MTHFR

Methylenetetrahydrofolate reductase

mTOR

Mammalian target of rapamycin

MTP

Metatarsal phalangeal (joint)

MTX

Methotrexate

MUD

Matched unrelated donor

MUGA

Multi gated acquisition scan

MVAC

Methotrexate, vinblastine, doxorubicin, cisplatin

MZL

Marginal zone lymphoma

N/V

Nausea and/or vomiting

NASH

Non-alcoholic steatohepatitis

NB-UVB

Narrowband ultraviolet B

NCCN

National comprehensive cancer network

NCI

National cancer institute

NDA

New drug application

NDV

Newcastle Disease Virus

NEC

Neuroendocrine carcinoma

NED

No evidence of disease

Neoadj

Neoadjuvant

NER

Nucleotide excision repair

NETs

Neuroendocrine tumors

NG

Nasogastric

NGS

Next generation sequencing

NGT

Nasogastric tube

NHEJ

Nonhomologous end joining

NHL

Non-Hodgkinlymphoma

NK

Natural killer

nl

Normal

NLPHL

Nodular Lymphocyte Predominant Hodgkin Lymphoma

NM

Neuromuscular

NMP22

Nuclear matrix protein 22

NNT

Number needed to treat

NO

Nitric oxide

NR

Not reported

NS

Normal saline

NSAID

Nonsteroidal anti-inflammatory drug

NSCLC

Non-small cell lung cancer

NSE

Neuron specific enolase

NSGCTs

Nonseminomatous germ cell tumors

NuRD

Nucleosome remodelling & histone deacetylase

NVE

Native valve endocarditis

NYHA

New York Heart Association

O/D

Overdose

o/w

Otherwise

OBD

Optimal biologic dose/optimum biologic dose

OCP

Oral contraceptive pill

OGCT

Ovarian germ cell tumor

ONJ

Osteonecrosis of jaw

OR

Odds ratio

ORR

Objective response rate or overall response rate

OS

Overall survival

OV

Oncolytic viruses

OX

Oxaliplatin

P/D

Pleurectomy/decortication

p/w

Present(s) with

PA

Pulmonary artery

PanIN

Pancreatic intraepithelial neoplasia

PAP

Prostatic acid phosphatase

PARP

Poly ADP ribose polymerase

PARP

Poly (ADP-ribose) polymerase

pb

Problem

PBGD

Porphobilinogen deaminase

PBMC

Peripheral blood mononuclear cells

PC

Prostate cancer

 

Plasma cell

PCA

Principle components analysis

PCALCL

Primary cutaneous ALCL

PCI

Prophylactic Cranial Irradiation

PCL

Primary CNS lymphoma

PCN

Penicillin

PCNA

Proliferating cell nuclear antigen

PCNSLs

Primary CNS lymphomas

PCOS

Polycystic Ovary Syndrome

PCP

Pneumocystis jiroveci pneumonia

pCR

Pathologic complete response

PCR

Polymerase chain reaction

PCT

Porphyria cutanea tarda

PCV

Polycythemia vera

 

Procarbazine, Lomustine, Vincristine

PD

Parkinson’s disease

 

Pharmacodynamics

 

Peritoneal dialysis

PDGF

Platelet-derived growth factor

PDGFR

Platelet-derived growth factor receptor

PDT

Photodynamic therapy

PE

Pulmonary embolism

peme

Pemetrexed

PET

Positron emission tomography

PEx

Physical examination

PFS

Progression-free survival

PFT

Pulmonary function test

PGA

Polyglandular autoimmune syndrome

PGDE

Pharmacologically-guided dose-escalations

P-gp

P-glycoprotein

PI

Principal investigator

PK

Pharmacokinetics

 

Pyruvate Kinase

PLAP

Placenta-like alkaline phosphatase

PLCO

Prostate, Lung, Colorectal, & Ovarian

PLL

Prolymphocytic leukemia

plt

Platelet

PMF

Primary myelofibrosis

PML

Progressive multifocal leukoencephalopathy

PMN

Polymorphonuclear leukocyte

PNA

Pneumonia

PNET

Primitive neuroectodermal

pNETs

Pancreatic NETs

PNETs

Pancreatic neuroendocrine tumors

PNH

Paroxysmal nocturnal hemoglobinuria

PNI

Perineural invasion

PO

Oral intake

POD

Progression of disease

polyA

Polyadenylated

POMA

Postoperative margin assessment

PORT

Postoperative RT

PPI

Proton pump inhibitors

Ppx

Prophylaxis

PR

Partial response

 

PR segment on ECG

 

Pulmonary regurgitation

PRCA

Pure red cell aplasia

prev

Prevention

PRL

Prolactin

PS

Performance status

 

Pressure support

 

Pulmonic stenosis

PSA

Prostate specific antigen

PSAV

Prostate specific antigen velocity

PSC

Primary sclerosing cholangitis

PSMA

Prostate specific membrane antigen

Pt

Patient

PT

Prothrombin time

PTH

Parathyroid hormone

PTH-rP

Parathyroid hormone-related peptide

PTHrp

PTH-related protein

PTLD

Post-transplant lymphoproliferative disorders

PUVA

Psoralen plus ultraviolet A

PV

Portal vein

qhs

Every bedtime

QoL

Quality of life

r/i

Rule in

r/o

Rule out

RA

Refractory anemia

RAI

Radioactive iodine

RAR

Retinoic acid receptor

RARS

Refractory Anemia w/ringed sideroblasts

RAS

Renal artery stenosis

RB1

Retinoblastoma 1

RBC

Red blood cell

RBE

Relative biologic effectiveness

RCC

Renal cell carcinoma

RCMD

Refractory cytopenia w/multilineage dysplasia

RCT

Randomized controlled trial

RDW

Red cell distribution width

RE

Reticuloendothelial

RF

Risk factor

RFA

Radiofrequency embolization

RFS

Recurrence-free survival

RI

Reticulocyte index

RIC

Reduced-intensity Conditioning

RIT

Radioimmunotherapy

RMSF

Rocky Mountain spotted fever

ROC

Receiver operating characteristic

ROS

Review of systems

ROTI

Related Organ or Tissue Impairment

RP

Radical prostatectomy

RP

Retroperitoneum

RP2D

Recommended phase 2 dose

RR

Relative risk/risk ratio

RR

Response rate

RR

Ribonucleotide reductase

rrBSO

Risk-reducing bilateral salpingo-oophorectomy

RS

Recurrence score

RS

Ringed sideroblasts

RSV

Respiratory syncytial virus

RT

Radiation therapy

RTA

Renal tubular acidosis

RUQ

Right upper quadrant

Rx

Therapy

rxn

Reaction

s/e

Side effect

s/p

Status post

s/s

Signs and symptoms

SAA

Serum amyloid A

SABR

Stereotactic ablative body radiotherapy

SBE

Subacute bacterial endocarditis

SBP

Spontaneous bacterial peritonitis

SBRT

Stereotactic body RT

SBS

Sequencing by synthesis

SC

Subcutaneous

SCC

Squamous cell carcinoma

SCID

Severe combined immunodeficiency

SCLC

Small cell lung cancer

SCr

Serum creatinine

SCT

Stem cell transplantation

SD

Stable disease

SDH

Succinate dehydrogenase

Se

Sensitivity

SEER

Surveillance Epidemiology and End Results

SERD

Selective estrogen receptor down-regulator

SERM

Selective estrogen receptor modulator

sev.

Severe

SFLC

Serum free light chain assay

SIADH

Syndrome of inappropriate antidiuretic hormone

SIF

Serum immunofixation

SIRS

Systemic inflammatory response syndrome

SLE

Systemic lupus erythematosus

SLL

Small lymphocytic lymphoma

SMA

Superior mesenteric artery

SM-

Systemic mastocytosis w/

AHNMD

 

associated hematologic non-mast cell lineage disorder

SMILE

Steroid, MTX, ifosfamide, L-asparaginase, etoposide

SMRP

Soluble mesothelin-related peptide

SMV

Superior mesenteric vein

SMX

Sulfamethoxazole

SNB

Sentinel node biopsy

SNP

Single nucleotide polymorphisms

SOB

Sulphur-oxidizing bacteria

SOM

Self-Organizing Maps

SOS

Sinusoidal obstructive syndrome

Sp

Specificity

SPEP

Serum protein electrophoresis

SPT

Second primary tumors

SPTCL

Subcutaneous panniculitis-like T cell lymphoma

SQCLC

Squamous cell lung cancer

SRE

Skeletal-related event

SRS

Stereotactic radiosurgery

SS

Sézary syndrome

SSC

Side Scatter

SSM

Smoldering systemic mastocytosis

SSRI

Selective serotonin reuptake inhibitor

SSS

Surgical Staging System

STD

Sexually transmitted disease

STIC

Serous tubular intraepithelial ca

STLI

Subtotal lymphocyte irradiation

STS

Soft tissue sarcomas

SUV

Standard uptake value

SVC

Superior vena cava

sx

Symptom(s)

TACE

Transarterial chemoembolization

TACO

Transfusion-associated circulatory overload

TAE

Transarterial embolization

TAH

Total abdominal hysterectomy

TB

Tuberculosis

TBI

Total body irradiation

TC

Thymic carcinoma

TCA

Tricyclic antidepressant

TCR

T cell receptors

TdT

Terminal deoxynucleotidyl transferase

TEPA

Tetraethylenepentamine

TFTs

Thyroid function tests

TG

Triglycerides

TIA

Transient ischemic attack

TIBC

Total iron binding capacity

TIL

Tumor infiltrating lymphocytes

TITE-CRM

Time to event-CRM

TK

Tyrosine kinase

TKI

Tyrosine kinase inhibitor

TLI

Total lymphocyte irradiation

TLR7

Toll-like receptor 7

TLS

Tumor lysis syndrome

TME

Total mesorectal excision

TMP

Trimethoprim

TMPT

Thiopurine methyltransferase

Tn

Troponin

TN

True negative/true –

TNF

Tumor necrosis factor

TNM

Tumor, node, metastasis

tox

Toxicity

TP

True positive/true +

TPN

Total parenteral nutrition

Tpo

Thrombopoietin

TPO

Thyroid peroxidase

TRALI

Transfusion-related acute lung injury

Treg

Regulatory T cells

TRUS

Transrectal ultrasound

TS

Thymidylate synthase

TSC

Tuberous sclerosis complex

TSEB

Total skin electron beam

TSEBT

Total skin electron beam therapy

TSGs

Tumor suppressor genes

TSH

Thyroid stimulating hormone

TSS

Toxic shock syndrome

 

Transsphenoidal surgery

TTF-1

Thyroid Transcription Factor-1

TTP

Thrombotic thrombocytopenic purpura

TTP

Time to progression

TTR

Transthyretin

TTTF

Time to treatment failure

tx

Treatment

U/A

Urinalysis

U/S

Ultrasound

UA

Unstable angina

 

Uric acid

UC

Ulcerative colitis

UC

Urothelial Carcinoma

UCB

Umbilical cord blood

UFH

Unfractionated heparin

UIF

Urine immunofixation

UGT1A1

Uridine Diphosphate Glucuronosyltransferase 1A1

ULN

Upper limit of normal

UOP

Urine output

UPEP

Urine protein electrophoresis

URI

Upper respiratory tract infection

UROD

Uroporphyrinogen decarboxylase

usu

Usually

UTI

Urinary tract infection

VAC

Vincristine + doxorubicin + cyclophosphamide

VEGF

Vascular endothelial growth factor

VEGFR

Vascular endothelial growth factor receptor

VelP

Vinblastine, ifosfamide, and cisplatin

VF

Ventricular fibrillation

VHL

Von hippel-lindau

VIDE

Vincristine + ifosfamide + doxorubicin + etoposide

VIE

Vincristine + doxorubicin + ifosfamide

VOC

Vaso-occlusive Crisis

VOD

Veno-occlusive disease

VP

Variegate porphyria

VRE

Vancomycin resistant enterococcus

VSV

Vesicular stomatitis virus

VTE

Venous thromboembolus

vWD

von Willebrand disease

vWF

von Willebrand factor

VZV

Varicella zoster virus

w/

With

w/c

Which

w/in

Within

w/o

Without

w/u

Workup

WBC

White blood cell (count)

WBRT

Whole brain RT

WHO

World Health Organization

wk

Week

WM

Waldenström macroglobulinemia

wt

Weight

WT

Wilms tumor

βB

Beta-blocker

γ

Gamma rays


Previous
Page
Next
Page